Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,713 | 666 | 99.2% |
| Education | $94.15 | 3 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $2,321 | 152 | $0 (2024) |
| ABBVIE INC. | $2,007 | 123 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,285 | 62 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $774.91 | 36 | $0 (2024) |
| Galderma Laboratories, L.P. | $612.90 | 48 | $0 (2024) |
| GENZYME CORPORATION | $509.91 | 22 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $459.97 | 22 | $0 (2024) |
| Amgen Inc. | $361.90 | 25 | $0 (2024) |
| Lilly USA, LLC | $359.74 | 20 | $0 (2024) |
| LEO Pharma Inc. | $261.81 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,022 | 97 | ABBVIE INC. ($345.59) |
| 2023 | $2,223 | 128 | Janssen Biotech, Inc. ($561.34) |
| 2022 | $1,622 | 89 | ABBVIE INC. ($406.42) |
| 2021 | $923.38 | 54 | AbbVie Inc. ($257.08) |
| 2020 | $678.56 | 36 | Janssen Biotech, Inc. ($217.99) |
| 2019 | $1,398 | 79 | Novartis Pharmaceuticals Corporation ($197.17) |
| 2018 | $1,674 | 100 | Janssen Biotech, Inc. ($366.85) |
| 2017 | $1,267 | 86 | Janssen Biotech, Inc. ($312.99) |
All Payment Transactions
669 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.38 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.24 | General |
| Category: Immunology | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.98 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $17.04 | General |
| 11/06/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: Dermatology | ||||||
| 10/30/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $26.29 | General |
| Category: Dermatology | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: DERMATOLOGY | ||||||
| 10/23/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: DERMATOLOGY | ||||||
| 10/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.67 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $28.22 | General |
| Category: Dermatology | ||||||
| 10/08/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.24 | General |
| Category: Immunology | ||||||
| 10/02/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Inflammation & Immunology | ||||||
| 10/01/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 3,253 | 4,598 | $663,844 | $245,678 |
| 2022 | 22 | 2,662 | 3,650 | $529,038 | $187,475 |
| 2021 | 24 | 3,221 | 4,690 | $665,407 | $252,335 |
| 2020 | 28 | 3,824 | 5,240 | $728,889 | $263,804 |
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,097 | 1,353 | $225,686 | $86,311 | 38.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 245 | 271 | $51,970 | $19,550 | 37.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 359 | 438 | $55,196 | $17,912 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 184 | 203 | $47,819 | $16,968 | 35.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 176 | 194 | $41,596 | $16,175 | 38.9% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 124 | 136 | $31,327 | $11,254 | 35.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 58 | 73 | $24,516 | $9,463 | 38.6% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 83 | 90 | $23,329 | $8,939 | 38.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 167 | 185 | $19,396 | $7,326 | 37.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 95 | 95 | $19,731 | $7,151 | 36.2% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 57 | 62 | $16,043 | $6,544 | 40.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 238 | 919 | $22,975 | $4,893 | 21.3% |
| 11306 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 43 | 47 | $10,910 | $3,799 | 34.8% |
| 11312 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 26 | 26 | $7,697 | $3,504 | 45.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 57 | 73 | $6,925 | $3,119 | 45.0% |
| 96900 | Application of ultraviolet light to skin | Office | 2023 | 14 | 152 | $7,034 | $3,080 | 43.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $7,382 | $3,028 | 41.0% |
| 10040 | Acne surgery | Office | 2023 | 26 | 27 | $5,926 | $2,253 | 38.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 21 | 21 | $4,984 | $1,999 | 40.1% |
| 11307 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 18 | 19 | $4,998 | $1,929 | 38.6% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 16 | 18 | $5,019 | $1,813 | 36.1% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 12 | 12 | $4,349 | $1,803 | 41.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 13 | 13 | $4,143 | $1,690 | 40.8% |
| 11310 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 19 | 20 | $4,418 | $1,373 | 31.1% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 11 | 16 | $3,766 | $1,351 | 35.9% |
About Dr. Elizabeth Voye, DO
Dr. Elizabeth Voye, DO is a Dermatology healthcare provider based in Jenkintown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1841295177.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elizabeth Voye, DO has received a total of $11,807 in payments from pharmaceutical and medical device companies, with $2,022 received in 2024. These payments were reported across 669 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($11,713).
As a Medicare-enrolled provider, Voye has provided services to 12,960 Medicare beneficiaries, totaling 18,178 services with total Medicare billing of $949,293. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Jenkintown, PA
- Active Since 06/14/2005
- Last Updated 03/31/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1841295177
Products in Payments
- TREMFYA (Drug) $1,137
- SKYRIZI (Biological) $1,010
- DUPIXENT (Biological) $794.45
- REMICADE (Biological) $771.15
- COSENTYX (Biological) $763.82
- COSENTYX (Drug) $521.37
- Humira (Biological) $483.19
- TALTZ (Drug) $359.74
- Otezla (Drug) $321.25
- Tremfya (Drug) $311.80
- ILUMYA (Biological) $303.37
- EPIDUO FORTE (Drug) $250.75
- Sotyktu (Drug) $240.27
- VTAMA (Drug) $212.85
- DUPIXENT (Drug) $212.77
- DORYX (Drug) $210.90
- DUPIXENT DUPILUMAB INJECTION (Biological) $210.64
- RINVOQ (Biological) $204.23
- STELARA (Biological) $199.27
- HUMIRA (Biological) $184.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Jenkintown
Atsuko Kodama, Md, Phd, MD, PHD
Dermatology — Payments: $12,266
Dr. David Dunaway, M.d, M.D
Dermatology — Payments: $11,809
Karl Hoegler, Md, MD
Dermatology — Payments: $1,498
Dr. Robert Fox, M.d, M.D
Dermatology — Payments: $307.06